Motherboard

Jayud Announces Agreement with Zhuhai Xiaomi Communications, the World-Renowned Smartphone Maker Xiaomi's Subsidiary, to Provide Customs Services

Retrieved on: 
Tuesday, September 5, 2023
Partnership, Electronics, Internet of things, Xiaomi, Hong Kong Stock Exchange, JYD, Motherboard, Growth, Ecosystem, S. D. Warren Co. v. Maine Board of Environmental Protection, Mobile phone

This partnership is designed to streamline and optimize Xiaomi's international cargo operations, including import and export customs clearances and related services at each port.

Key Points: 
  • This partnership is designed to streamline and optimize Xiaomi's international cargo operations, including import and export customs clearances and related services at each port.
  • Under the terms of the agreement, Jayud will use its extensive technology and in-house expertise to simplify the complexity of Xiaomi's international cargo operations.
  • Zhuhai Xiaomi Communications Co., Ltd, established in January 2013, has been at the forefront of smartphone technology, providing innovative products and solutions to consumers within the globe.
  • Meanwile, Xiaomi is the third-largest smartphone maker in China.

Chuncheng Heating Maintains High-Quality Development in 1H2023, Net profit Increases 95.9% year-on-year to RMB125 Million

Retrieved on: 
Tuesday, September 5, 2023
China National Intellectual Property Administration, Maintenance, Police Technology Department, Stock exchange, Intelligence, Research, Motherboard, Engineering, Economic development, Publicity Department of the Chinese Communist Party, Heat, AI, Renewable energy

Gross profit increased significantly by 77.2% to RMB226 million, primarily due to decrease in heat procurement costs, coal procurement, labor workers as well as utilities costs, etc.

Key Points: 
  • Gross profit increased significantly by 77.2% to RMB226 million, primarily due to decrease in heat procurement costs, coal procurement, labor workers as well as utilities costs, etc.
  • Net profit margin was 13.9% with earnings per share at RMB0.27.
  • It continued to improve its management system for heat supply production and enhanced the level of applying intelligence in heat supply business.
  • During the Period, the Group's revenue generated from heat supply business was RMB879 million, up by 2.1% year-on-year.

EEKA Fashion Announces 2023 Interim Results, Net Profit Increased 71.57%

Retrieved on: 
Monday, August 28, 2023
Acceleration, Learning, Omnichannel, World Oceans Day, Exhibition, R & D, Culture, HK, Research, Tmall, Quotations from Chairman Mao Tse-tung, World Ocean Review, Motherboard, Magic: The Gathering core sets, 1993–2007, S. D. Warren Co. v. Maine Board of Environmental Protection, Video game, Management, Retail

HONG KONG, Aug 28, 2023 - (ACN Newswire) - EEKA Fashion Holdings Limited ("EEKA Fashion" or the "Company", together with its subsidiaries, the "Group", stock code: 3709.HK) announces the unaudited results for the six months ended 30 June 2023 (the "Reporting Period").

Key Points: 
  • HONG KONG, Aug 28, 2023 - (ACN Newswire) - EEKA Fashion Holdings Limited ("EEKA Fashion" or the "Company", together with its subsidiaries, the "Group", stock code: 3709.HK) announces the unaudited results for the six months ended 30 June 2023 (the "Reporting Period").
  • Net profit margin sharply increased from 8.90% for the first half of 2022 to 13.24%.
  • The revenue from the self-operated retail stores increased by 19.44% from RMB2,279.81 million for the first half of 2022 to RMB2,722.99 million for the Reporting Period.
  • For more information, please visit EEKA Fashion's website: http://www.eekagroup.com/
    This press release is issued by Financial PR (HK) Limited on behalf of EEKA Fashion Holdings Limited.

ADICON Holdings Limited One of the Top Three ICL Service Providers in China is Successfully Listed on Main Board of SEHK

Retrieved on: 
Friday, June 30, 2023
Carlyle, Mindray, ICL, Stock exchange, Motherboard, Growth, Seemabaddha

Morgan Stanley Asia Limited and Jefferies Hong Kong Limited are the Joint Sponsors, Overall Coordinators, Joint Global Coordinators, Joint Bookrunners and Joint Lead Managers.

Key Points: 
  • Morgan Stanley Asia Limited and Jefferies Hong Kong Limited are the Joint Sponsors, Overall Coordinators, Joint Global Coordinators, Joint Bookrunners and Joint Lead Managers.
  • ADICON has also entered into cornerstone investment agreements with investors including MR Global (HK) Limited (Mindray), Snibe Diagnostic (Hong Kong) Company Limited, Fosun Diagnostics (Shanghai) Co., Ltd., Timestar Elite Limited and Corelink.
  • Ms. YANG Ling, Chairwoman and Non-Executive Director of ADICON Holdings Limited, and Managing Director at Carlyle Asia, commented: "ADICON is one of the top three ICL service providers in China and an industry pioneer.
  • We believe the ICL market in China is still in a nascent stage and there remains significant room for the industry to grow.

New Media Lab Announces Proposed Listing on The Main Board of SEHK

Retrieved on: 
Thursday, June 29, 2023
Advertising, The New Monday, Travel, Share, Habit, Orient, Data collection, Stock exchange, Social media, Digest, Parenting, Motherboard, SEO, Beauty, Main Board for Serb Liberation, SEHK, Guotai Junan Securities, News, Property management, Limited

HONG KONG, June 29, 2023 - (ACN Newswire) - New Media Lab Limited ("New Media Lab" or the "Group", Stock Code: 1284.HK), a renowned digital media flagship group in Hong Kong, today announced the details of its share offer (the "Share Offer") and proposed listing on the Main Board of The Stock Exchange of Hong Kong Limited ("SEHK").

Key Points: 
  • HONG KONG, June 29, 2023 - (ACN Newswire) - New Media Lab Limited ("New Media Lab" or the "Group", Stock Code: 1284.HK), a renowned digital media flagship group in Hong Kong, today announced the details of its share offer (the "Share Offer") and proposed listing on the Main Board of The Stock Exchange of Hong Kong Limited ("SEHK").
  • Emperor Corporate Finance Limited and Lego Corporate Finance Limited are the Joint Sponsors of the Group's listing.
  • Dealings in the shares of the Group will commence on the Main Board of SEHK on 17 July 2023 (Monday) under the stock code 1284.
  • New Media Lab is a digital media flagship group, providing one-stop integrated advertising solutions to brand owners and advertising agencies through a number of digital media platforms.

Laekna, a Biotechnology Company in China, Listed on the Main Board of the Hong Kong Stock Exchange

Retrieved on: 
Thursday, June 29, 2023
IIA, Stock exchange, Bimagrumab, Prednisone, Sintilimab, Patient, Investment, Federal Medical Centres, Mab, Cornerstone, Prostate cancer, Biomedical Research, Clinical trial, Hepatic stellate cell, Research, Motherboard, Drug discovery, Knowledge, FDA, IND, Frost, Cirrhosis, Global Health Innovative Technology Fund, International, Biotechnology, Cancer, Breakthrough therapy, AKT, Core product, CYP17A1, CYP11B2, Social responsibility, Drug development, Liver disease, ATP, Drug resistance, Trust, Limited partnership, Multi, Hong Kong Stock Exchange, SCGC, HK, Management, Pharmaceutical industry, IPO, Novartis

HONG KONG, June 29, 2023 - (ACN Newswire) - A biotechnology company in China - Laekna, Inc. (stock code: 2105.HK), today listed on the Main Board of The Stock Exchange of Hong Kong Limited (the "Hong Kong Stock Exchange").

Key Points: 
  • HONG KONG, June 29, 2023 - (ACN Newswire) - A biotechnology company in China - Laekna, Inc. (stock code: 2105.HK), today listed on the Main Board of The Stock Exchange of Hong Kong Limited (the "Hong Kong Stock Exchange").
  • (2) Use for advancing the clinical development and approval of the other Core Product of the Company, LAE002.
  • The Hong Kong Offering also recorded an over-subscription, of approximately 5.81 times of the 6,373,000 shares offered.
  • The Company has established a number of global and regional partnerships with leading pharmaceutical companies, including Novartis and Innovent.

ADICON Announces Proposed Listing on the Main Board of The Stock Exchange of Hong Kong at an Offer Price of HK$12.32 Per Share

Retrieved on: 
Monday, June 19, 2023
IPO, Mindray, Marketing, Stock exchange, Hematology, GH, Helmy Eltoukhy, Hospital, Cornerstone, Transport, Automation, Bruce High Quality Foundation, Atmosphere, NGS, Infection, Mass spectrometry, Motherboard, Laboratory, Knowledge, Growth, ChromeOS, ICL, COVID-19, SEHK, Flow cytometry, Nested polymerase chain reaction, Seemabaddha, Quality control, Carlyle, Partnership, CGP, University, EBITDA, Trust, Physician, City, Property management, Video game, Health insurance, Pharmaceutical industry, Warehouse, Fine chemical, Airline, Management, Audit, Medical device

-- ADICON will start its public offering in Hong Kong at 9:00 a.m. on Monday, 19 June 2023, and end at 12:00 noon on Friday, 23 June 2023.

Key Points: 
  • -- ADICON will start its public offering in Hong Kong at 9:00 a.m. on Monday, 19 June 2023, and end at 12:00 noon on Friday, 23 June 2023.
  • Dealings in shares on the Main Board of The Stock Exchange of Hong Kong Limited ("SEHK") are expected to commence on Friday, 30 June 2023, with the stock code of 9860.HK, in board lots of 500 shares each.
  • -- Morgan Stanley Asia Limited and Jefferies Hong Kong Limited are the Joint Sponsors, Overall Coordinators, Joint Global Coordinators, Joint Bookrunners and Joint Lead Managers.
  • ADICON believes its quality assurance has positioned it strongly to broaden its customer base and capture an increasing market share.

YSB Inc. Global Offering

Retrieved on: 
Thursday, June 15, 2023
Danna International (Offer Nissim Presents), International, SFC, Stock exchange, International Underwriting Association, Research, Cornerstone, Listing Rules, Motherboard, China International Capital Corporation, ZGC, The Company, Shanghai Stock Exchange, Lead management, ABCI, Joint, AFRC, HK, Video game, Property management, Holding company, Security (finance), Life insurance, Share (finance), Limited

HONG KONG, June 15, 2023 - (ACN Newswire) - YSB Inc. (the "Company"; Stock code: 9885) announced the details of its global offering (the "Global Offering") and its proposed listing on the Main Board of The Stock Exchange of Hong Kong Limited (the "Stock Exchange").

Key Points: 
  • HONG KONG, June 15, 2023 - (ACN Newswire) - YSB Inc. (the "Company"; Stock code: 9885) announced the details of its global offering (the "Global Offering") and its proposed listing on the Main Board of The Stock Exchange of Hong Kong Limited (the "Stock Exchange").
  • Highlights of the Global Offering:
    -- Number of Offer Shares under the Global Offering: 15,808,800 Shares (subject to the Over-allotment Option).
  • Assuming that the Over-allotment Option is not exercised, after deducting the underwriting commissions and other estimated offering expenses payable by us in connection with the Global Offering, and assuming an Offer Price of HK$21.00 per Share (being the mid-point of the Offer Price), the Company estimates that it will receive gross proceeds of approximately HK$332.0 million from the Global Offering, and net proceeds of approximately HK$253.6 million from the Global Offering.
  • The Cornerstone Placing will form part of the International Offering, and Cornerstone Investor will not acquire any Offer Shares under the Global Offering (other than pursuant to the Cornerstone Investment Agreement).

Xuanzhu Biopharm, a subsidiary of Sihuan Pharmaceutical, progresses at full speed in innovative research and development Presents major research results of birociclib, the start product, at the international stage in ASCO

Retrieved on: 
Thursday, June 8, 2023
Brain, Drug development, CDK6, Diabetes, American Society of Clinical Oncology, Stock exchange, Traffic barrier, Research, Sihuan Pharmaceutical, Drug design, Motherboard, ASCO, HKEX, Metabolism, Patient, Non-Euclidean geometry, The Company, R, CD80, CDK4, Society, III, Safety, Breast cancer, Pharmaceutical industry, Fine chemical

The excellent clinical results disclosed by Xuanzhu Biopharm at the ASCO annual meeting highlighted the development potential of birociclib.

Key Points: 
  • The excellent clinical results disclosed by Xuanzhu Biopharm at the ASCO annual meeting highlighted the development potential of birociclib.
  • We have over 40 medical aesthetics products and over 50 innovative drugs, many of which have already entered the harvesting stage.
  • Currently, Xuanzhu Biopharm has over 10 products approved to conduct clinical trials, and over 10 drug candidates in the preclinical development stage.
  • For more information about Sihuan Pharmaceutical, please visit the Company's website at https://www.sihuanpharm.com/
    Source: Sihuan Pharmaceutical Holdings Group Ltd.

Chow Tai Fook Jewellery Delivers Growth in Same Store Sales and Retail Sales Value in First Quarter FY2024

Retrieved on: 
Monday, July 10, 2023
ASP, Omnichannel, Collection, SSS, Marketing, Culture, VAT, POS, Platinum, Stock exchange, Creativity, Motherboard, Phase 10, RSV, Gold, Traction, Love, SEHK, Growth, City, Same-store sales, HK, Grand Kerala Shopping Festival, Cryptocurrency, Tourism, Property management, Jewellery, Renewable energy, Video game

(2) “Same Store Sales” for the First Quarter is the RSV from the self-operated POS of CHOW TAI FOOK JEWELLERY existing as at 30 June 2023 and which have been opened prior to 1 April 2022.

Key Points: 
  • (2) “Same Store Sales” for the First Quarter is the RSV from the self-operated POS of CHOW TAI FOOK JEWELLERY existing as at 30 June 2023 and which have been opened prior to 1 April 2022.
  • (Hong Kong, China, 10 July 2023) Chow Tai Fook Jewellery Group Limited (“Chow Tai Fook Jewellery Group”, the “Group” or the “Company”; SEHK stock code: 1929), today announces unaudited key operational data of the Group for the three months ended 30 June 2023 (the “First Quarter”, or the “Quarter” or “1QFY2024”).
  • Same Store Sales (“SSS”) in the Mainland recorded positive growth of 8.5%.
  • In the Mainland, the Same Store ASP of gem-set jewellery was benefitted from increased sales of higher ticketsize jewellery during the Quarter.